Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

TVTXTVTX
22 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in TRAVERE THERAPEUTICS INC

Yes. Two Sigma holds 1,565,656 shares of TVTX (Travere Therapeutics), worth $88.9M, as of its Q2 2026 13F filing. It increased the position by 57,397 shares (+3.8%) from Q1 2026. Two Sigma has held TVTX since Q4 2023, across 11 quarterly 13F filings. TVTX is 0.1% of Two Sigma's reported 13F portfolio.

Current Value

$88.9M

Current Shares

1.6M

Total Value Change

+$87.9M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+3.8%
$88.9M0.1%$56.81
31
2026-Q1
Increased
1.5M
+30.4%
$44.8M0.0%$29.71
37
2025-Q4
Increased
1.2M
+24.5%
$44.2M0.1%$38.21
36
2025-Q3
Increased
928,998
+1.1%
$22.2M0.0%$23.90
29
2025-Q2
Increased
918,713
+19.5%
$13.6M0.0%$14.80
33
2025-Q1
Increased
768,794
+10.9%
$13.8M0.0%$17.92
31
2024-Q4
Increased
693,016
+92.5%
$12.1M0.0%$17.42
44
2024-Q3
Increased
360,083
+14.6%
$5M0.0%$13.99
31
2024-Q2
Decreased
314,180
-41.8%
$2.6M0.0%$8.22
0
2024-Q1
Increased
540,084
+46.5%
$4.2M0.0%$7.71
36
2023-Q4
New
368,669
-
$3.3M0.0%$8.99
37
2023-Q3
Exited
0
-100.0%
$00.0%$8.94
0
2023-Q2
Decreased
441,267
-20.3%
$6.8M0.0%$15.36
0
2023-Q1
Increased
553,713
+176.8%
$12.5M0.0%$22.49
45
2022-Q4
Increased
200,011
+83.2%
$4.2M0.0%$21.03
41
2022-Q3
Decreased
109,166
-45.5%
$2.7M0.0%$24.64
0
2022-Q2
Decreased
200,333
-7.5%
$4.9M0.0%$24.23
0
2022-Q1
Increased
216,587
+122.4%
$5.6M0.0%$25.77
44
2021-Q4
New
97,400
-
$3M0.0%$31.04
37
2021-Q2
Exited
0
-100.0%
$00.0%$14.59
0
2021-Q1
Decreased
33,550
-15.4%
$838,0000.0%$24.97
0
2020-Q4
New
39,637
-
$1.1M0.0%$27.26
35

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used